SCHEMBL16836769

SCHEMBL16836769

CCOC(=O)c1ncc(C)c(N)c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 2/20 0.44
GABRP O00591 1/20 0.44
GABRD O14764 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRB1 P18505 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
GABRA4 P48169 1/20 0.44
GABRE P78334 1/20 0.44
GABRA6 Q16445 1/20 0.44
GABRG1 Q8N1C3 1/20 0.44
GABRG3 Q99928 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7669745 0.80 MAPT (0.48) ALDH1A1MEN1KMT2AMAPTGABRP
SCHEMBL17512466 0.77 CYP1A2 (0.46) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL28050636 0.77 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AMAPTGABRP
SCHEMBL16836849 0.75 MAPT (0.42) ALDH1A1MEN1KMT2AMAPTGABRP
SCHEMBL392723 0.74 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AMAPTGABRP
SCHEMBL24131085 0.73 CYP1A2 (0.46) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL18404967 0.73 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL28634780 0.73 BRD4 (0.49) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL13622778 0.73 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AMAPTGABRA1
SCHEMBL25765775 0.72 KDM4E (0.46) ALDH1A1KMT2AMAPTGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005721-B2 Dimethylbenzoic acid compounds ELI LILLY AND COMPANY (US) 2018-06-26 US disclosed
US-10005721-B2 Dimethylbenzoic acid compounds ELI LILLY AND COMPANY (US) 2018-06-26 US disclosed
US-10005721-B2 Dimethylbenzoic acid compounds ELI LILLY AND COMPANY (US) 2018-06-26 US disclosed
EP-3083554-A1 DIMETHYLBENZOIC ACID COMPOUNDS Eli Lilly & Company (US) 2016-10-26 EP disclosed
US-20160251306-A1 DIMETHYLBENZOIC ACID COMPOUNDS ELI LILLY AND COMPANY 2016-09-01 US disclosed
US-20160251306-A1 DIMETHYLBENZOIC ACID COMPOUNDS ELI LILLY AND COMPANY 2016-09-01 US disclosed
US-20160251306-A1 DIMETHYLBENZOIC ACID COMPOUNDS ELI LILLY AND COMPANY 2016-09-01 US disclosed
WO-2015094912-A1 DIMETHYLBENZOIC ACID COMPOUNDS ELI LILLY AND COMPANY (US) 2015-06-25 WO disclosed
WO-2015094912-A1 DIMETHYLBENZOIC ACID COMPOUNDS ELI LILLY AND COMPANY (US) 2015-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005721-B2 Dimethylbenzoic acid compounds PTGER4, EDNRB, EPB41 ALDH1A1 272/4885MEN1 2770/4885KMT2A 516/4885
US-20160251306-A1 DIMETHYLBENZOIC ACID COMPOUNDS PTGER4, EDNRB, EPB41 ALDH1A1 272/4885MEN1 2770/4885KMT2A 516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.